Follow
Jonas Walter
Jonas Walter
Novo Nordisk Center for Protein Research
Verified email at cpr.ku.dk - Homepage
Title
Cited by
Cited by
Year
Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression
N Govindarajan, RC Agis-Balboa, J Walter, F Sananbenesi, A Fischer
Journal of Alzheimer's Disease 26 (1), 187-197, 2011
3792011
Derivation of human midbrain-specific organoids from neuroepithelial stem cells
AS Monzel, LM Smits, K Hemmer, S Hachi, EL Moreno, T van Wuellen, ...
Stem cell reports 8 (5), 1144-1154, 2017
3682017
Distinct antimicrobial peptide expression determines host species-specific bacterial associations
S Franzenburg, J Walter, S Künzel, J Wang, JF Baines, TCG Bosch, ...
Proceedings of the National Academy of Sciences 110 (39), E3730-E3738, 2013
3272013
3D cultures of Parkinson's disease‐specific dopaminergic neurons for high content phenotyping and drug testing
S Bolognin, M Fossépré, X Qing, J Jarazo, J Ščančar, EL Moreno, ...
Advanced Science 6 (1), 1800927, 2019
1132019
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
T Narita, S Ito, Y Higashijima, WK Chu, K Neumann, J Walter, S Satpathy, ...
Molecular cell 81 (10), 2166-2182. e6, 2021
982021
FACS-assisted CRISPR-Cas9 genome editing facilitates Parkinson's disease modeling
J Arias-Fuenzalida, J Jarazo, X Qing, J Walter, G Gomez-Giro, SL Nickels, ...
Stem Cell Reports 9 (5), 1423-1431, 2017
982017
Neural stem cells of Parkinson's disease patients exhibit aberrant mitochondrial morphology and functionality
J Walter, S Bolognin, PMA Antony, SL Nickels, SK Poovathingal, ...
Stem cell reports 12 (5), 878-889, 2019
852019
CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
X Qing, J Walter, J Jarazo, J Arias-Fuenzalida, AL Hillje, JC Schwamborn
Stem Cell Research 24, 44-50, 2017
722017
Parkinson's disease phenotypes in patient neuronal cultures and brain organoids improved by 2‐Hydroxypropyl‐β‐Cyclodextrin treatment
J Jarazo, K Barmpa, J Modamio, C Saraiva, S Sabaté‐Soler, I Rosety, ...
Movement Disorders 37 (1), 80-94, 2022
432022
Impaired mitochondrial–endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson’s disease
C Berenguer-Escuder, D Grossmann, P Antony, G Arena, K Wasner, ...
Human molecular genetics 29 (8), 1353-1364, 2020
382020
The Parkinson’s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1
J Walter, S Bolognin, SK Poovathingal, S Magni, D Gerard, PMA Antony, ...
Cell Reports 37 (3), 2021
242021
Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients
SL Nickels, J Walter, S Bolognin, D Gérard, C Jaeger, X Qing, J Tisserand, ...
Parkinsonism & Related Disorders 67, 48-55, 2019
192019
Automated high-throughput high-content autophagy and mitophagy analysis platform
J Arias-Fuenzalida, J Jarazo, J Walter, G Gomez-Giro, JI Forster, ...
Scientific Reports 9 (1), 9455, 2019
152019
Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes
T Narita, Y Higashijima, S Kilic, T Liebner, J Walter, C Choudhary
Nature Genetics 55 (4), 679-692, 2023
102023
Parkinson’s disease phenotypes in patient specific brain organoids are improved by HP-β-CD treatment
J Jarazo, K Barmpa, I Rosety, LM Smits, J Arias-Fuenzalida, J Walter, ...
BioRxiv, 813089, 2019
102019
A unique H2B acetylation signature marks active enhancers and predicts their target genes
T Narita, Y Higashijima, S Kilic, T Liebner, J Walter, C Choudhary
bioRxiv, 2022.07. 18.500459, 2022
62022
2-hydroxypropyl-beta-cyclodextrin for use in a method of treatment of a parkinsonian condition
J Jarazo, J Walter, J Schwamborn
WO Patent WO2019219741A1, 2019
22019
Human induced pluripotent stem cell-derived neuronal progenitors are a suitable and effective drug discovery model for neurological mtDNA disorders
J Walter, SL Nickels, JC Schwamborn
Stem Cell Investigation 4, 2017
22017
Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c. 815G> A …
A Chemla, G Arena, G Onal, J Walter, C Berenguer-Escuder, ...
Stem Cell Research 71, 103145, 2023
12023
Parkinson's disease associated embryonic neurodevelopmental phenotypes
J Walter, S Nickels, J Arias, X Qing, J Jarazo, F Noel, K Tronstad, ...
HUMAN GENE THERAPY 27 (11), A80-A80, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20